임상 데이터 분석 솔루션 시장 : 솔루션, 용도, 최종 용도, 세계 전망

Clinical Data Analytics Solutions Market size is set to record 12.8% CAGR from 2024 to 2032 due to the rise in collaborations within the healthcare sector. Solution providers and technology firms are integrating these solutions to streamline patient care and improve treatment outcomes. Stakeholders are collaborating to harness the power of predictive analytics and AI to personalize patient care and optimize healthcare delivery.

With the evolving healthcare systems, these partnerships are helping in improving patient outcomes through data-driven insights and collaborative efforts. For instance, in April 2024, IQVIA and Salesforce announced an expanded global strategic partnership to integrate IQVIAs clinical data analytics solutions with Salesforce Life Sciences Cloud. This collaboration helped enhance customer engagement in the global life sciences industry through advanced analytics and a unified platform.

The clinical data analytics solutions industry is segmented into solution, application, end-use, and region.

By solution, the market size from the services segment will record a decent growth rate between 2024 and 2032, due to the adoption of advanced analytics to interpret patient data effectively. These services are enabling healthcare providers to make data-driven decisions in real time for enhancing patient care and treatment strategies. Clinical data analytics are also integrated with emerging technologies like AI and machine learning to further optimize healthcare delivery while ensuring efficient and effective healthcare management for patients and providers.

In terms of application, the clinical data analytics solutions market from the precision health segment is anticipated to witness significant CAGR from 2024-2032. Precision health is revolutionized by clinical data analytics solutions which are utilizing advanced analytics to analyze individual health data with unprecedented accuracy. These solutions are enabling healthcare providers to tailor treatments and interventions based on personalized insights derived from extensive data sets. Lately, several precision health initiatives are also advancing for integrating gnomic data, wearable technology, and real-time monitoring to further refine predictive models and treatment strategies.

Asia Pacific clinical data analytics solutions industry size will record significant CAGR through 2032 due to the widespread adoption of telehealth and remote patient monitoring technologies. These innovations are enabling healthcare providers to deliver care remotely by leveraging advanced analytics to monitor patient health data in real time.With the evolving healthcare delivery, telehealth and remote monitoring is facilitating more accessible and efficient healthcare services across diverse populations in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing adoption of electronic health records (EHRs)
    • 3.2.1.2 Rising demand for real-time data insights to enhance patient outcomes
    • 3.2.1.3 Growth in clinical studies for developing new therapeutics
    • 3.2.1.4 Growing demand for mitigating the risk of failures in clinical studies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Security and privacy concerns related to clinical data
    • 3.2.2.2 Issues related to data quality and integration
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Solution, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Platform
  • 5.2.1 Cloud-based
  • 5.2.2 On-premise
• 5.3 Services
  • 5.3.1 Consulting services
  • 5.3.2 Integration and implementation services
  • 5.3.3 Support and maintenance services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Clinical decision support
• 6.3 Precision health
• 6.4 Quality improvement and clinical bench marking
• 6.5 Regulatory reporting and compliance
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical and biotechnology companies
• 7.3 Providers
• 7.4 Payers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Allscripts Healthcare Solutions, Inc.
• 9.2 CareCloud Corporation
• 9.3 Cerner Corporation
• 9.4 Dassault Systemes
• 9.5 eClinical Solutions LLC

96 Inspirata Inc.

• 9.7 IQVIA Inc.
• 9.8 Medeanalytics, Inc.
• 9.9 Medical Information Technology Inc.
• 9.10 Optum, Inc.
• 9.11 Oracle Corporation
• 9.12 Qsi Management LLC
• 9.13 SAS Institute, Inc.
• 9.14 Truven Health Analytics, Inc.
• 9.15 Verisk Analytics, Inc